FTRE
Price
$17.69
Change
-$0.12 (-0.67%)
Updated
Jan 17 closing price
Capitalization
1.59B
57 days until earnings call
MGTX
Price
$6.26
Change
+$0.33 (+5.56%)
Updated
Jan 17 closing price
Capitalization
489.24M
52 days until earnings call
Ad is loading...

FTRE vs MGTX

Header iconFTRE vs MGTX Comparison
Open Charts FTRE vs MGTXBanner chart's image
Fortrea Holdings
Price$17.69
Change-$0.12 (-0.67%)
Volume$497.59K
Capitalization1.59B
MeiraGTx Holdings
Price$6.26
Change+$0.33 (+5.56%)
Volume$445.64K
Capitalization489.24M
FTRE vs MGTX Comparison Chart
Loading...
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FTRE vs. MGTX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTRE is a Hold and MGTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (FTRE: $17.69 vs. MGTX: $6.26)
Brand notoriety: FTRE and MGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FTRE: 46% vs. MGTX: 159%
Market capitalization -- FTRE: $1.59B vs. MGTX: $489.24M
FTRE [@Biotechnology] is valued at $1.59B. MGTX’s [@Biotechnology] market capitalization is $489.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FTRE’s FA Score shows that 1 FA rating(s) are green whileMGTX’s FA Score has 0 green FA rating(s).

  • FTRE’s FA Score: 1 green, 4 red.
  • MGTX’s FA Score: 0 green, 5 red.
According to our system of comparison, MGTX is a better buy in the long-term than FTRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FTRE’s TA Score shows that 1 TA indicator(s) are bullish while MGTX’s TA Score has 4 bullish TA indicator(s).

  • FTRE’s TA Score: 1 bullish, 6 bearish.
  • MGTX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, MGTX is a better buy in the short-term than FTRE.

Price Growth

FTRE (@Biotechnology) experienced а -2.75% price change this week, while MGTX (@Biotechnology) price change was +0.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

FTRE is expected to report earnings on Mar 17, 2025.

MGTX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FTRE($1.59B) has a higher market cap than MGTX($489M). MGTX YTD gains are higher at: 2.791 vs. FTRE (-5.147). FTRE has higher annual earnings (EBITDA): 7.1M vs. MGTX (-61.2M). MGTX has more cash in the bank: 123M vs. FTRE (105M). MGTX has less debt than FTRE: MGTX (86.7M) vs FTRE (1.2B). FTRE has higher revenues than MGTX: FTRE (2.98B) vs MGTX (13.9M).
FTREMGTXFTRE / MGTX
Capitalization1.59B489M325%
EBITDA7.1M-61.2M-12%
Gain YTD-5.1472.791-184%
P/E RatioN/AN/A-
Revenue2.98B13.9M21,410%
Total Cash105M123M85%
Total Debt1.2B86.7M1,389%
FUNDAMENTALS RATINGS
MGTX: Fundamental Ratings
MGTX
OUTLOOK RATING
1..100
85
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FTREMGTX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 11 days ago
85%
Bearish Trend 11 days ago
90%
Momentum
ODDS (%)
Bearish Trend 11 days ago
77%
Bullish Trend 11 days ago
84%
MACD
ODDS (%)
Bearish Trend 11 days ago
62%
Bullish Trend 11 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
75%
Bullish Trend 11 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
72%
Bullish Trend 11 days ago
79%
Advances
ODDS (%)
Bullish Trend 13 days ago
71%
Bullish Trend 16 days ago
81%
Declines
ODDS (%)
Bearish Trend 11 days ago
78%
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 11 days ago
80%
View a ticker or compare two or three
Ad is loading...
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JATNX63.690.80
+1.27%
Janus Henderson Glb Tech and Innovt N
JICPX15.400.18
+1.18%
JHFunds2 Capital Appreciation 1
MDDLX10.100.07
+0.70%
MassMutual Diversified Value Adm
ACFFX26.050.13
+0.50%
Columbia Acorn International Sel Inst
EMCAX67.45-0.16
-0.24%
Empiric Class A

FTRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FTRE has been loosely correlated with RVNC. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if FTRE jumps, then RVNC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FTRE
1D Price
Change %
FTRE100%
-0.67%
RVNC - FTRE
34%
Loosely correlated
+12.54%
TECH - FTRE
33%
Loosely correlated
-0.35%
RIGL - FTRE
33%
Poorly correlated
+16.02%
CORT - FTRE
32%
Poorly correlated
+1.60%
MGTX - FTRE
31%
Poorly correlated
+5.56%
More

MGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with BEAM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGTX
1D Price
Change %
MGTX100%
+5.56%
BEAM - MGTX
54%
Loosely correlated
+0.17%
NTLA - MGTX
54%
Loosely correlated
+0.85%
CRSP - MGTX
51%
Loosely correlated
+0.57%
AURA - MGTX
50%
Loosely correlated
+1.30%
PRME - MGTX
50%
Loosely correlated
+0.70%
More